Skip to main content

What the FDA labels say about taking them together

Cobicistat and felodipine

Cobicistat's FDA label of February 10, 2026 names felodipine in its drug interactions section; the felodipine label PlainMeds reads does not name cobicistat. The cobicistat label: “Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.”

Check it at the source: the cobicistat FDA label on DailyMed (effective February 10, 2026, Gilead Sciences, Inc.); the felodipine FDA label on DailyMed (effective August 11, 2026, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.).

What does the cobicistat label say about felodipine?

Cobicistat label, drug interactions

Concomitant Drug Class/Drug Name: Calcium Channel Blockers: e.g., amlodipine diltiazem felodipine nifedipine verapamil; Potential Effect ↑ = Increase, ↓ = Decrease, ↔ = No change: ↑ calcium channel blockers; Clinical Comment: Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.

Source: FDA drug label (Tybost), Gilead Sciences, Inc., effective February 10, 2026 (SPL set 3784c35c-e87f-410c-900b-8fd6313c6010), via openFDA; the full label on DailyMed

What does the felodipine label say about cobicistat?

Felodipine's label (effective August 11, 2026) does not name cobicistat in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (FELODIPINE), Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., effective August 11, 2026 (SPL set 0bef7cf2-012b-4804-ac93-0a8b333035db), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Cobicistat generic labelers
14Felodipine generic labelers
CobicistatFelodipine
Labeled forHIVHigh blood pressure
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$0.123 per tablet 5 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?